Session: Characterization and Processing Solutions for API and Drug Product (2010 Annual Meeting)

Description:

Second session to accommodate high submission rate.

Sponsor:

Pharmaceuticals

Chair:

Marylee Z. Southard
University of Kansas
Chemical & Petroleum Engrg. Dept.
1530 W. 15th Street, Room 4132
Lawrence, KS 66045
Phone Number: 785-864-3868
Fax Number: 785-864-4967
Email: marylee@ku.edu

Co-Chair:

Hector Guzman
Process Engineering
Alkermes
Cambridge, MA 02421
Phone Number: 781-674-7882
Fax Number: 781-863-8914
Email: hector.guzman@alkermes.com

Papers:

320a

Raman Chemical Mapping Vs. NIR Spectroscopy for Assessing the API Distribution and Coating Thickness of Tablets
Nicolas Heigl, Research Center Pharmaceutical Engineering GmbH; Gudrun Hoerl, Research Center Pharmaceutical Engineering GmbH; Daniel Koller, Research Center Pharmaceutical Engineering GmbH; Walter Tritthart, G.L. Pharma GmbH; Franz Reiter, G.L. Pharma GmbH; Merten Schlingmann, G.L. Pharma GmbH; Johannes Khinast, Research Center Pharmaceutical Engineering GmbH

320b

Determination of the API Distribution in Tablets as a Result of Processing Parameters Using Laser Induced Breakdown Spectroscopy
Dan Braido, Rutgers University; Atul Dubey, Rutgers University; Alberto Cuitino, Rutgers University; Fernando Muzzio, Rutgers University

320c

Crystallization From Solutions Containing Multiple Conformers: Approach of the Right Conformer
Lotfi Derdour, Bristol-Myers Squibb Co; Shawn K. Pack, Bristol-Myers Squibb Co; Dimitri Skliar, Bristol-Myers Squibb Co; Chiajen J. Lai, Bristol-Myers Squibb Co; San Kiang, Bristol-Myers Squibb Co

320d

Flow Improvement of Pharmaceutical Blends Via Surface Modification of Cohesive APIs
Rajesh Dave, New Jersey Center for Engineered Particulates; Lakxmi Gurumurthy, New Jersey Center for Engineered Particulates; Chinmay Ghoroi, New Jersey Center for Engineered Particulates; David Harris, Merck Research Laboratories,

320e

Combining Formulation and Process Aspects for Optimizing the High-Shear Wet Granulation of Common Drugs
Mauro Cavinato, University of Padua; Enrico Andreato, University of Padua; Massimo Bresciani, GlaxoSmithKline; Isabella Pignatone, GlaxoSmithKline; Guido Bellazzi, GlaxoSmithKline; Erica Franceschinis, University of Padua; Nicola Realdon, University of Padua; Paolo Canu, University of Padua; Andrea C. Santomaso, University of Padua

320f

High Drug Loading High Shear Wet Granulation
Lixia Cai, Merck & Co., Inc.; Leon Farber, Merck & Co., Inc.; Dina Zhang, Merck & Co., Inc.

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division

<< Previous Session | Next Session >>